This article contains wording that promotes the subject through exaggeration of unnoteworthy facts .(July 2020) |
Professor Kefah Mokbel MBBS MS FRCS | |
---|---|
Born | 1965 Syria |
Education | Concord College |
Alma mater | University of London |
Occupation | Surgeon |
Professor Kefah Mokbel FRCS is currently the chair of breast cancer surgery and the multidisciplinary breast cancer program at the London Breast Institute of the Princess Grace Hospital part of HCA Healthcare, Professor (Honorary) of Breast Cancer Surgery at Brunel University London, an honorary consultant breast surgeon at St George's Hospital. Kefah Mokbel is the founder and current president of Breast Cancer Hope; a UK-based charity "dedicated to improving the quantity and quality of life in women diagnosed with breast cancer". [1] He was appointed as a substantive consultant breast surgeon at St George's Hospital NHS trust in February 2001. He was named in Tatler magazine's Best Doctors Guide as one of the featured "Top Breast Surgeons" in 2006, 2007 and 2013. [2] In November 2010 he was named in the Times magazine's list of Britain's Top Doctors. [3]
Kefah Mokbel was born in 1965 in the currently occupied Golan Heights in Syria. At the end of junior high school, he was awarded a national scholarship after he passed the Brevet des collèges in Syria (1980). In 1983 he was awarded a scholarship to study medicine in the United Kingdom after completing the Syrian Baccalaureate national examination with full marks. Kefah Mokbel learned English in Eastbourne and then studied A levels in a boarding school (Concord College) in Shrewsbury. He graduated (MB, BS) from the University of London in 1990. He qualified as a Fellow of the Royal College of Surgeons (FRCS, England) in 1994. He was granted the Master of Surgery degree in 2000 by The Imperial College of Science, Technology and Medicine for his research in the field of molecular biology of breast cancer.
In 2002, Mokbel was appointed an Honorary Professor at The Brunel Institute of Cancer Genetics and Pharmacogenomics at Brunel University in recognition of his contribution to breast cancer research. [4] In 2005, he was appointed as a Reader in Breast Surgery at St George's University of London in recognition of his outstanding research contribution in the field of breast cancer. [5]
Mokbel's clinical interests in the field of breast surgery include the early detection of breast cancer, breast ductoscopy, minimally-invasive breast surgery, sentinel node biopsy, skin-sparing mastectomy, breast reconstruction, cosmetic breast surgery, prevention of breast cancer, genetic predisposition, integrative oncology and the management of benign conditions including breast cysts, mastalgia and fibroadenomas. [6] Mokbel has extensive experience in the field of reconstructive and aesthetic breast surgery including augmentation mammoplasty (replacement of implants and correction of contracture), reduction mammoplasty and mastopexy.
Mokbel's main research interest lies in the field of molecular biology and the clinical management of breast cancer. Furthermore, he has published several papers in the field of aesthetic breast surgery including breast reconstruction following mastectomy and augmentation mammoplasty using implants and fat transfer. His prolific research output includes over 400 published papers [7] in medical literature. According to Google Scholar Kefah Mokbel has 400 publications [8] which have been cited more than 8000 times with a H-index of 57 and an i10-index of 204. Furthermore, his research linked the SET domain containing protein 2 (SETD2) gene to human breast cancer. [9] He has also written 14 books [10] in various disciplines including surgery, oncology, breast cancer, and postgraduate medical education. Mokbel is a member of the editorial board of several international medical journals [11] [12] [13] [14] and a peer reviewer for medical journals including The Lancet.
In October 2017 Mokbel and his team reported through a metaanalysis that the use of hair dyes could be associated with a 20% increase in breast cancer risk. [15]
In October 2018, Mokbel and his team reported that the use of testosterone gel for hyposexual desire might not increase breast cancer risk among women using it. [16]
Kefah Mokbel has been also featured in many publications and interviews regarding breast cancer and surgery in the national and international media including: The Times , [17] The Daily Telegraph , [18] The Guardian , [19] New York Post , the BBC, [20] ITV, NBC Washington, [21] Hello Magazine , [22] ABC News, [23] MSN, Yahoo, The Daily Express , [24] The Independent , [25] The Medical Daily, [26] The Evening Standard, [27] Daily Mirror , [28] Marie Claire and British Sky Broadcasting. [29] He also writes medical articles for totalhealth and is one of totalhealth's specialist consultants. [30] [31] In 2013, Kefah Mokbel featured on BBC world news regarding the news that actress Angelina Jolie had preventative double mastectomy after finding that she is a BRCA1 gene carrier. [32] He was depicted by Silas Carson in the BBC drama The C Word, about his real-life patient Lisa Lynch. [33]
This section of a biography of a living person needs additional citations for verification .(December 2020) |
Mokbel is currently the Chair of Breast Surgery at The London Breast Institute of The Princess Grace Hospital, the chair of the multidisciplinary breast cancer program of the London Breast Institute, Professor (Honorary) of Breast Cancer Surgery (Brunel University, London)[ citation needed ], Honorary Consultant Breast Surgeon at St George's Hospital (London, UK) and President of Breast Cancer Hope Foundation.
Mastectomy is the medical term for the surgical removal of one or both breasts, partially or completely. A mastectomy is usually carried out to treat breast cancer. In some cases, women believed to be at high risk of breast cancer have the operation as a preventive measure. Alternatively, some women can choose to have a wide local excision, also known as a lumpectomy, an operation in which a small volume of breast tissue containing the tumor and a surrounding margin of healthy tissue is removed to conserve the breast. Both mastectomy and lumpectomy are referred to as "local therapies" for breast cancer, targeting the area of the tumor, as opposed to systemic therapies, such as chemotherapy, hormonal therapy, or immunotherapy.
Mammaplasty refers to a group of surgical procedures, the goal of which is to reshape or otherwise modify the appearance of the breast. There are three main types of mammoplasty:
Robert Maurice Lipson Winston, Baron Winston is a British professor, medical doctor, scientist, television presenter and Labour peer.
Sir Geoffrey Langdon Keynes was a British surgeon and author. He began his career as a physician in World War I, before becoming a doctor at St Bartholomew's Hospital in London, where he made notable innovations in the fields of blood transfusion and breast cancer surgery. Keynes was also a publishing scholar and bibliographer of English literature and English medical history, focusing primarily on William Blake and William Harvey.
Daniel F. Roses is an American surgeon who is the Jules Leonard Whitehill Professor of Surgery and Oncology of the New York University School of Medicine and a Senior Attending Surgeon at Tisch Hospital of the New York University Medical Center.
Bernard Fisher was an American surgeon and a pioneer in the biology and treatment of breast cancer. He was a native of Pittsburgh. He was Chairman of the National Surgical Adjuvant Breast Project at the University of Pittsburgh School of Medicine. His work established definitively that early-stage breast cancer could be more effectively treated by lumpectomy, in combination with radiation therapy, chemotherapy, and/or hormonal therapy, than by radical mastectomy.
Colonel Sir George Thomas Beatson was a British physician. He was a pioneer in the field of oncology, developing a new treatment for breast cancer, and has been called "the father of endocrine ablation in cancer management." The Beatson West of Scotland Cancer Centre and the Cancer Research UK Beatson Institute are named for him.
Sir Bruce Anthony John Ponder FMedSci FAACR FRS FRCP is an English geneticist and cancer researcher. He is Emeritus Professor of Oncology at the University of Cambridge and former director of the Cancer Research UK Cambridge Institute and of the Cancer Research UK Cambridge Cancer Centre.
Jan Měšťák(born August 26, 1944) is a Czech physician specializing in plastic surgery, university lecturer, head of the Department of Plastic Surgery at the First Faculty of Medicine of Charles University and University Hospital Bulovka in Prague and its founder.
A preventive mastectomy or prophylactic mastectomy or risk-reducing mastectomy (RRM) is an elective operation to remove the breasts so that the risk of breast cancer is reduced.
The Japanese Foundation for Cancer Research (公益財団法人がん研究会) (JFCR) is a non-profit cancer research organization based in Ariake, Tokyo. The JFCR was founded in 1908 as the first Japanese organization specializing in cancer by Katsusaburō Yamagiwa and his supporters. The Cancer Institute and its attached hospital of JFCR were set up in 1934. The JFCR became a full member of the Union for International Cancer Control in 1968.
Krystal Barter is a health activist, author and founder of Humanise Health, A patient-led & advocacy agency working with leading businesses in the health sector who make it their purpose to positively impact lives.
Kristi Funk is an American breast cancer surgeon known for her surgical treatment of celebrities Angelina Jolie and Sheryl Crow and her advocacy of whole-food plant-based nutrition.
Lisa Lynch was a British journalist, known for writing about her experience of having cancer on her blog, Alright Tit, and in a book, The C-Word. She was portrayed by Sheridan Smith in the 90-minute BBC television drama, The C-Word, written by Nicole Taylor and directed by Tim Kirkby.
Syrians in the United Kingdom or Syrian Britons are people whose heritage is originated from Syria who were born in or who reside in the United Kingdom.
Prevent Breast Cancer is a UK charity funding research solely aimed at preventing breast cancer. The Manchester-based charity aims to promote early diagnosis of breast cancer, improve cancer screenings, and change the habits and lifestyles of high-risk patients. Based at The Nightingale Centre & Prevent Breast Cancer Research Centre in Wythenshawe, Manchester, where the NHS co-ordinates the breast-screening programme for the Greater Manchester area.
Patrick Stewart Boulter FRCS, FRCSEd was a general surgeon in Guildford, England. He developed a sub-speciality interest in breast surgery and was one of the pioneers in the UK of screening for breast cancer. He served as president of the Royal College of Surgeons of Edinburgh from 1991 to 1994.
Jayant S. Vaidya is a British-Indian surgeon-oncologist and clinical academic who, together with Michael Baum and Jeffrey Tobias, developed the technique called targeted intra-operative radiotherapy (TARGIT). He is a professor of surgery and oncology at the University College London, London and the author of two books on breast cancer, one on tobacco eradication, and over 200 academic articles.
Somashekhar SP is an Indian robotic surgeon, author and chairman of medical advisory board at Aster DM Healthcare - GCC & India. He is also the global director of Aster International Institute of Oncology in GCC & India. He is the president of the Association of Breast Surgeons of India, editor in chief of the IJGO Springer Indian Journal of Gynec Oncology and council member of The Association of Surgeons of India. He is also the editor of Annals of Breast Diseases.
Lisa J. M. Caldon is a British professor and clinical lecturer specialising in oncology. In her 20 year career, Caldon has published some 20 papers in the field of medicine. These have appeared in some of the top medical and peer-reviewed journals in Britain and abroad, including Medical Education, the European Journal of Cancer, the British Journal of Surgery, Patient Education and Counseling, Psycho-Oncology, Future Oncology, BMC Medical Informatics and Decision Making, and The Lancet Oncology. Caldon has worked at The University of Sheffield and with Cancer Research UK.
{{cite web}}
: CS1 maint: archived copy as title (link)